Drug Profile
BRL 38277
Latest Information Update: 29 May 2001
Price :
$50
*
At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Heart failure therapies
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Heart failure